DPHARMA
Quarterly rpt on consolidated results for the financial period ended 31 Dec 2018
CCM DUOPHARMA BIOTECH BERHAD |
Financial Year End | 31 Dec 2018 |
Quarter | 4 Qtr |
Quarterly report for the financial period ended | 31 Dec 2018 |
The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
31 Dec 2018
|
31 Dec 2017
|
31 Dec 2018
|
31 Dec 2017
|
||
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
1 | Revenue |
115,634
|
112,253
|
498,722
|
467,987
|
2 | Profit/(loss) before tax |
17,658
|
12,801
|
59,666
|
51,772
|
3 | Profit/(loss) for the period |
14,369
|
12,131
|
47,641
|
42,463
|
4 | Profit/(loss) attributable to ordinary equity holders of the parent |
14,369
|
12,131
|
47,641
|
42,463
|
5 | Basic earnings/(loss) per share (Subunit) |
2.17
|
1.86
|
7.26
|
6.52
|
6 | Proposed/Declared dividend per share (Subunit) |
4.00
|
2.57
|
5.50
|
3.64
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
0.7300
|
0.7400
|
Remarks : |
Pursuant to MFRS 133 Earnings Per Share, the Basic Earnings Per Share, Dividend Per Share and Net Assets Per Share for the corresponding quarter and year to date 31 December 2017 had been retrospectively adjusted to reflect the effect of the bonus issue. |
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
Country | Base Unit | Subunit |
Malaysia | Ringgit | Sen |
United States | Dollar | Cent |
United Kingdom | Pound | Pence |
Announcement Info
Company Name | CCM DUOPHARMA BIOTECH BERHAD |
Stock Name | CCMDBIO |
Date Announced | 18 Feb 2019 |
Category | Financial Results |
Reference Number | FRA-11022019-00012 |